Literature DB >> 14694187

Are SOCS suppressors, regulators, and degraders?

James A Johnston1.   

Abstract

Suppressors of cytokine signaling have been identified as inhibitors of cytokine signaling and have been shown to act in a classical feedback loop. The prototype members of this family, cytokine-inducible Src homology 2-containing protein and suppressors of cytokine signaling SOC was cloned as cytokine-inducible immediate early gene that could inhibit the activation of signal transducer and activator of transcription factors and block biological responses to several cytokines. Although steady progress has been made in the identification of SOCS and their physiological importance, precisely how SOCS proteins function has not yet been discovered. Many recent findings indicate that the SOCS act as adaptors that regulate the turnover of certain substrates by interacting with and activating an E3 ubiquitin ligase. Here, I explore recent evidence (presented at the International Cytokine Society meeting in Dublin, Ireland, September 2003) that SOCS molecules may not act simply as regulators of cytokine responses but may also play an essential role in determining cell fate and controlling cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694187     DOI: 10.1189/jlb.1003507

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  22 in total

1.  Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.

Authors:  Y Gui; M Yeganeh; Y-C Donates; W-S Tobelaim; W Chababi; M Mayhue; A Yoshimura; S Ramanathan; C Saucier; S Ilangumaran
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

Review 2.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

3.  SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Authors:  Lerin R Luckett-Chastain; Michael A Ihnat; Bethany M Mickle-Kawar; Randle Michael Gallucci
Journal:  J Interferon Cytokine Res       Date:  2012-02-07       Impact factor: 2.607

4.  Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.

Authors:  Joanne Elliott; Oonagh T Lynch; Yvonne Suessmuth; Ping Qian; Caroline R Boyd; James F Burrows; Richard Buick; Nigel J Stevenson; Olivier Touzelet; Massimo Gadina; Ultan F Power; James A Johnston
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

6.  SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation.

Authors:  Gillian M Tannahill; Joanne Elliott; Anna C Barry; Linda Hibbert; Nicolas A Cacalano; James A Johnston
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve.

Authors:  Elizabeth I Girolami; Delphine Bouhy; Michael Haber; Howard Johnson; Samuel David
Journal:  Exp Neurol       Date:  2009-07-02       Impact factor: 5.330

8.  Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes.

Authors:  Brandi J Baker; Hongwei Qin; Etty N Benveniste
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

9.  Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1.

Authors:  Atsushi Okumura; Paula M Pitha; Akihiko Yoshimura; Ronald N Harty
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

10.  Mechanism of attenuation of leptin signaling under chronic ligand stimulation.

Authors:  Holger Knobelspies; Julia Zeidler; Paul Hekerman; Simone Bamberg-Lemper; Walter Becker
Journal:  BMC Biochem       Date:  2010-01-08       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.